Literature DB >> 6452679

Factual or artificial inhibition of fibrinolysis and the occurrence of venous thrombosis in 3 cases of Behçet's disease.

C Kluft, J J Michiels, G Wijngaards.   

Abstract

3 patients with Behçet's disease were studied for their fibrinolytic status during exacerbation of the disease accompanied with thrombotic complications. All 3 patients exhibited low euglobulin fibrinolytic activity. This, however, could be attributed to an artificially increased coprecipitation of inhibitors, i.e., C1-inactivator in the euglobulin fractions. This phenomenon correlated with and was possibly related to inflammatory reactions in the patients. The most severely diseased patient only showed an increased plasmin inhibition in the plasma and a decreased response to venous occlusion. The increased plasmin inhibition was due to a slow type of inhibition, which could not be attributed to known protease inhibitors in blood. Its physiological relevance to fibrinolysis is questionable. There was no evidence for relevant general deviations in the fibrinolytic system in Behçet's disease; only for the severe case may the decreased fibrinolytic potency revealed by venous occlusion have contributed to the extent of the thrombotic manifestations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6452679     DOI: 10.1111/j.1600-0609.1981.tb01424.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  5 in total

1.  Decreased protein S activity is related to the disease activity of Behcet's disease.

Authors:  Seong Ryul Kwon; Mie Jin Lim; Shin Goo Park; Yeon Sook Moon; Won Park
Journal:  Rheumatol Int       Date:  2006-09-13       Impact factor: 2.631

2.  Bilateral central retinal vein thrombosis in Behçet's disease.

Authors:  A M el-Asrar; A K al-Momen; S A Alamro; A G Gader; K F Tabbara
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

3.  Defective fibrinolysis in Behçet's syndrome: significance and possible mechanisms.

Authors:  R Aitchison; P Chu; D R Cater; R J Harris; R J Powell
Journal:  Ann Rheum Dis       Date:  1989-07       Impact factor: 19.103

4.  Vascular involvement in Behçet's disease: 8-year audit.

Authors:  M A Kuzu; C Ozaslan; C Köksoy; A Gürler; A Tüzüner
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

5.  Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behçet's disease.

Authors:  A Orem; O Değer; O Memiş; S Bahadir; E Ovali; G Cimşit
Journal:  Ann Rheum Dis       Date:  1995-09       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.